Advertisement

Reactions Weekly

, Volume 1748, Issue 1, pp 268–268 | Cite as

Ipilimumab/nivolumab/pembrolizumab

Thyroiditis: 3 case reports
Case report
  • 14 Downloads

Reference

  1. Garon-Czmil J, et al. Thyroiditis and immune check point inhibitors: the post-marketing experience using the French National Pharmacovigilance database. Fundamental and Clinical Pharmacology 33: 241-249, No. 2, Apr 2019. Available from: URL: http://doi.org/10.1111/fcp.12423 - France

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations